The post Médunik and Biocodex sign exclusive agreement for Diacomit in Canada appeared first on Hospital Management.
Médunik and Biocodex sign exclusive agreement for Diacomit in Canada
Hospital Management
·
·
6 views
Médunik Canada has entered into an exclusive promotional services agreement with Biocodex for Diacomit, a medication approved in Canada as an add-on therapy for seizures associated with Dravet syndrome. The post Médunik and Biocodex sign exclusive agreement for Diacomit in Canada appeared first on Hospital Management.
Healthieyoo 
Tim Ferriss 
Ditch That Textbook By Matt Miller 
MarkMeets » Entertainment 
The Educators Room 
The Wrap 
